New COPD Medicines captured in useful COPD decision support tool
So far this year there have been three new medicines released for patients with COPD.
- Glycopyrronium bromide (Seebri), once daily LAMA
- Aclidinium bromide (Bretaris), twice daily LAMA. The Genuair is the inhaler device for Bretaris. To view the inhaler device video contact Judy on 1800 654 301 or firstname.lastname@example.org.
- Indacaterol/glycopyrronium bromide (Ultibro), once daily LABA/LAMA
The Stepwise Management of Stable COPD is a one page evidence-based decision support tool outlining pharmacotherapy and non-pharmacotherapy options across the level of disease severity. Download the latest version of Stepwise Management of Stable COPD here <http://lungfoundation.com.au/wp-content/uploads/2014/02/LFA-Stepwise-Management-of-COPD_0216_WEB-1.pdf> to find out when medicines can be introduced and precautions around using them in combination.
Visit the website for the COPDX Guidelines www.copdx.org.au